Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Eur J Clin Nutr ; 69(12): 1369-70, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26373963

ABSTRACT

We report the successful treatment of autoimmune hypoglycemia in an 82-year-old non-diabetic Caucasian male with hydrothermally modified slow release corn starch, a product which is used in other conditions associated with hypoglycemia, most typically glycogen storage disease type I. An 82-year-old-Caucasian male presented with recurrent spontaneous hypoglycemia as low as 30 mg/dl following in-patient treatment for community acquired pneumonia. During a fasting-test, symptomatic hypoglycemia occurred. Plasma concentrations of c-peptide and insulin were considerably elevated. Autoimmune hypoglycemia was confirmed by the presence of insulin autoantibodies. While dietary restriction alone did not result in sufficient glucose control in this patient with autoimmune hypoglycemia, treatment with hydrothermally modified slow release corn starch led to stable euglycemia. This easy, well tolerated and non-invasive treatment may constitute a new therapeutic option for hypoglycemia in patients with autoimmune hypoglycemia who do not achieve sufficient control of hypoglycemia by dietary restriction alone.


Subject(s)
Delayed-Action Preparations/therapeutic use , Hypoglycemia/diet therapy , Starch/therapeutic use , Zea mays/chemistry , Aged, 80 and over , C-Peptide/blood , Delayed-Action Preparations/chemistry , Glycogen Storage Disease Type I/blood , Glycogen Storage Disease Type I/diagnosis , Glycogen Storage Disease Type I/diet therapy , Humans , Hypoglycemia/blood , Hypoglycemia/diagnosis , Insulin/blood , Insulin Antibodies/blood , Male , Starch/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL